SUNY-Buffalo: Research Published in NEJM Finds Kids and Young Adults Newly Diagnosed With Type 1 Diabetes Still Produce Insulin With Golimumab
November 19, 2020
November 19, 2020
BUFFALO, New York, Nov. 19 (TNSJou) -- The State University of New York Buffalo campus issued the following news release:
A multi-center study led by a University at Buffalo pediatric endocrinologist has found that a drug currently on the market for other autoimmune conditions can preserve the beta cells of children and young adults recently diagnosed with Type 1 diabetes for at least a year after diagnosis.
The research, published on Nov. 19 in The New England Journal . . .
A multi-center study led by a University at Buffalo pediatric endocrinologist has found that a drug currently on the market for other autoimmune conditions can preserve the beta cells of children and young adults recently diagnosed with Type 1 diabetes for at least a year after diagnosis.
The research, published on Nov. 19 in The New England Journal . . .